Abstract: A device for detecting an analyte in a sample is provided, which comprises: a collecting chamber containing an opening for collecting a liquid sample; a detecting element for detecting an analyte in the liquid sample; and a lid for covering the opening of the collecting chamber. The device further comprises an indicating device thereon to indicate whether or not the lid covers at an appointed position. The operation of the device is very simple.
Type:
Grant
Filed:
March 11, 2020
Date of Patent:
May 28, 2024
Assignee:
Abbott Rapid Diagnostics International Unlimited Company
Abstract: The present disclosure relates to methods of detecting a protein from the SARS-CoV-2 virus, or a fragment thereof, in a sample obtained from a subject using a first antibody or antigen-binding fragment thereof that binds to a protein from the SARS-CoV-2 virus, or a fragment thereof, and a second antibody or antigen-binding fragment thereof which binds to a protein from the SARS-CoV-2 virus, or a fragment thereof.
Type:
Grant
Filed:
August 4, 2021
Date of Patent:
May 21, 2024
Assignee:
Abbott Rapid Diagnostics International Unlimited Company
Inventors:
Lawrence B. Blyn, Mijung Ji, Stephen Kovacs, Anthony S. Muerhoff, Stacey P. Huth, Carsten Buenning, Tao Xin, Donabel Roberts, Sung Hee Kim, Sang Yong Park, Robert N. Ziemann
Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.
Type:
Grant
Filed:
June 30, 2021
Date of Patent:
November 14, 2023
Assignee:
ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
Inventors:
Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
Abstract: Provided herein is technology relating to methods for assaying a cell-containing body sample and particularly, but not exclusively, to treating a sample under conditions to cause cell lysis, preferably by means of a detergent; and subjecting the lysed sample to conditions causing the cleavage of nucleic acid molecules. The technology additionally relates to using nucleic acid cleavage conditions to enhance a membrane assay, a device for carrying out such an assay, and a kit for use in the assay.
Type:
Grant
Filed:
January 10, 2018
Date of Patent:
August 30, 2022
Assignee:
ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY
Inventors:
Jostein Holtlund, Andrew Campbell, Stig Morten Borch